Sign in

CIK 0001390478

  • Non-accelerated filer
  • Smaller reporting company

SELLAS Life Sciences Group, Inc.

Sign in to watch
Ticker
SLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 646-200-5278
Business address
7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
Former names
GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$716,682
in 3 filings

Net −$716,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2009-03-13 KRIEGSMAN STEVEN A Director Sale −900 $3.33 $3K 146,425
2009-03-12 KRIEGSMAN STEVEN A Director Sale −1,300 $3.34 $4K 174,684
2009-03-11 KRIEGSMAN STEVEN A Director Sale −2,700 $3.44 $9K 175,984
2009-03-10 KRIEGSMAN STEVEN A Director Sale −7,400 $3.17 $23K 178,684
2009-03-09 KRIEGSMAN STEVEN A Director Sale −4,500 $2.97 $13K 186,084
2009-03-06 KRIEGSMAN STEVEN A Director Sale −1,300 $3.32 $4K 190,584
2009-03-05 KRIEGSMAN STEVEN A Director Sale −2,100 $3.36 $7K 191,884
2009-03-04 KRIEGSMAN STEVEN A Director Sale −1,500 $3.56 $5K 193,984
2009-03-03 KRIEGSMAN STEVEN A Director Sale −2,900 $3.64 $11K 195,484
2009-03-02 KRIEGSMAN STEVEN A Director Sale −4,700 $3.76 $18K 198,384
2009-02-27 KRIEGSMAN STEVEN A Director Sale −1,300 $4.05 $5K 203,084
2009-02-26 KRIEGSMAN STEVEN A Director Sale −400 $4.25 $2K 204,384
2009-02-25 KRIEGSMAN STEVEN A Director Sale −1,800 $4.25 $8K 204,784
2009-02-24 KRIEGSMAN STEVEN A Director Sale −3,000 $4.40 $13K 206,584
2009-02-09 Hillsberg Sanford Director Gift −4,000 6,000
2009-01-15 Samarsky Dmitry VP, Technology Development Grant or award · Stock Option +30,000 158,260
2009-01-15 Woolf Tod President and CEO Grant or award · Stock Option +48,000 420,100
2009-01-15 DiPalma Stephen J. CFO, EVP, Secretary Grant or award · Stock Option +47,000 166,428
2009-01-15 DiPalma Stephen J. CFO, EVP, Secretary Grant or award · Stock Option +36,218 202,646
2009-01-15 Andrikopoulos Konstantinos VP, Legal Grant or award · Stock Option +100,000 100,000

Page 28 of 29 · 580 trades